• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    OraSure Technologies, Inc. (OSUR)

    -NasdaqGS
    5.14 Down 0.23(4.28%) Jul 2, 4:00PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    OraSure Technologies, Inc.
    220 East First Street
    Bethlehem, PA 18015
    United States - Map
    Phone: 610-882-1820
    Fax: 610-882-1830
    Website: http://www.orasure.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Instruments & Supplies
    Full Time Employees:320

    Business Summary 

    OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its primary products include OraQuick ADVANCE HIV-1/2, OraQuick In-Home HIV Test, OraQuick HCV, OraSure QuickFlu rapid flu A&B test, OraSure, Oragene DX, Oragene DNA, Oragene RNA, ORAcollect, OMNIgene DISCOVER, Performagene LIVESTOCK and Oragene ANIMAL, HEMAgen BUFFY COAT, PrepIT—MAX, OMNIgene—Gut, OMNIgene Sputum, Intercept, MICRO-PLATE DOA Assays, Intercept i2, Homogeneous DOA Assays, and professional and over-the-counter Cryosurgical Systems. In addition, the company manufactures and sells oral fluid collection devices used to collect, stabilize, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic testing, academic research, pharmacogenomics, personalized medicine, and animal genetics markets. Further, it provides medical devices used for the removal of benign skin lesions by cryosurgery or freezing; various immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid Western blot HIV-1 confirmatory test for confirming positive HIV-1 test; and Q.E.D. rapid point-of-care saliva alcohol test. The company sells its products to various clinical laboratories, hospitals, clinics, community-based organizations, public health organizations, research and academic institutions, distributors, government agencies, physicians’ offices, and commercial and industrial entities. OraSure Technologies, Inc. was founded in 1979 and is based in Bethlehem, Pennsylvania.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on OraSure Technologies, Inc.

    Corporate Governance 
    OraSure Technologies, Inc.’s ISS Governance QuickScore as of Jun 1, 2015 is 8. The pillar scores are Audit: 2; Board: 4; Shareholder Rights: 8; Compensation: 9.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Douglas A. Michels , 58
    Chief Exec. Officer, Pres and Director
    1.20M50.00K
    Mr. Ronald H. Spair , 59
    Chief Operating Officer, Chief Financial Officer and Director
    782.00K118.00K
    Mr. Mark L. Kuna , 51
    Principal Accounting Officer, Sr. VP of Fin., Controller and Assistant Sec.
    392.00K0.00
    Mr. Jack E. Jerrett , 56
    Sr. VP, Gen. Counsel and Sec.
    539.00K59.00K
    Mr. Anthony Zezzo II, 61
    Exec. VP of Marketing and Sales
    582.00K0.00
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders